 By John Vandermosten NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT First Quarter 2020 Operational and Financial Results On May 7, 2020 Lipocine NASDAQ:LPCN filed its first quarter 2020 10-Q and posted its earnings release for the three month period ending March 31, 2020. The company reported zero revenues and a net loss per share of 0.14 compared to prior year revenues of zero and loss of 